Table 4.
Univariate outcomes of patients characterized by race and ethnicity (N=24,102)
| Outcomes | Hispanic (N = 1933) |
Non-Hispanic Black (N = 4123) |
Non-Hispanic White (N = 18046) |
p-value | |||
|---|---|---|---|---|---|---|---|
| N | Prob (95% CI) |
N | Prob (95% CI) |
N | Prob (95% CI) |
||
| NRM | 1926 | 4104 | 18006 | 0.36‡ | |||
| 100 day | 0.6 (0.3–1)% | 0.6 (0.4–0.9)% | 0.9 (0.7–1)% | 0.15 | |||
| 1-year | 2 (2–3)% | 3 (2–3)% | 3 (2–3)% | 0.70 | |||
| PFS | 1926 | 4104 | 18006 | 1.0‡ | |||
| 1-year | 82 (80–84)% | 82 (81–83)% | 83 (82–83)% | 0.30 | |||
| 2-year | 66 (64–68)% | 66 (64–67)% | 66 (65–67)% | 0.93 | |||
| 3-year | 54 (51–56)% | 54 (52–55)% | 53 (52–54)% | 0.84 | |||
| OS | 1932 | 4120 | 18030 | 0.13‡ | |||
| 1-year | 94 (93–95)% | 94 (94–95)% | 94 (93–94)% | 0.26 | |||
| 2-year | 86 (85–88)% | 86 (85–87)% | 86 (85–86)% | 0.72 | |||
| 3-year | 80 (77–82)% | 79 (77–80)% | 77 (77–78)% | 0.05 | |||
Abbreviations: NRM, non-relapse mortality; PFS, progression-free survival; OS, overall survival